MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, CYRX made $47,798K in revenue. -$12,544K in net income. Net profit margin of -26.24%.

Income Overview

Revenue
$47,798K
Net Income
-$12,544K
Net Profit Margin
-26.24%
EPS
-$0.25
Unit: Thousand (K) dollars
Revenue Breakdown
    • Biologistics Solutions
    • Product
    • Biostorage Bioservices
Revenue Breakdown
    • Americas
    • EMEA
    • Asia Pacific

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Total revenue
47,798 45,450 44,233 45,454
Service
13,747 13,548* 12,201 12,449
Product
12,138 10,192* 10,707 11,628
Total cost of revenue
25,885 23,739 22,908 24,077
Gross margin
21,913 21,711 21,325 21,377
Selling, general and administrative
27,620 24,986 26,734 26,908
Engineering and development
3,907 4,466 4,523 4,118
Total operating costs and expenses
31,527 29,452 31,257 31,026
Loss from operations
-9,614 -7,741 -9,932 -9,649
Investment income
3,090 3,357 3,402 1,466
Interest expense, net
432 634 526 618
Other expense, net
-2,368 -87 525 -2,939
Total other income, net
290 2,636 3,401 -2,091
Loss from continuing operations before provision for income taxes
-9,324 -5,105 -6,531 -11,740
Provision for income taxes
108 1,126 165 274
Loss from continuing operations
-9,432 -6,231 -6,696 -12,014
Gain from discontinued operations, net
-1,112 -1,724 -247 117,194
Net gain
-10,544 -7,955 -6,943 105,180
Paid-in-kind dividend on series c convertible preferred stock
2,000 2,000 2,000 2,000
Net gain attributable to common stockholders
-12,544 -9,955 -8,943 103,180
Basic EPS
-0.25 -0.199 -0.18 2.05
Diluted EPS
-0.25 -0.199 -0.18 2.05
Basic Average Shares
49,897,817 49,957,268 50,125,268 50,257,112
Diluted Average Shares
49,897,817 49,957,268 50,125,268 50,257,112
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net gainattributable to common...-$12,544K (10.28%↑ Y/Y)Net gain-$10,544K (11.99%↑ Y/Y)Paid-in-kind dividend onseries c convertible...$2,000K (0.00%↑ Y/Y)Biologistics Solutions$21,668K (16.93%↑ Y/Y)Biostorage Bioservices$5,230K (20.67%↑ Y/Y)Loss from continuingoperations-$9,432K (-4.47%↓ Y/Y)Gain fromdiscontinued operations, net-$1,112K (62.34%↑ Y/Y)Investment income$3,090K (96.44%↑ Y/Y)Service$26,898K (17.64%↑ Y/Y)Product$20,900K (14.99%↑ Y/Y)Loss from continuingoperations before...-$9,324K (-6.03%↓ Y/Y)Provision for income taxes$108K (-53.85%↓ Y/Y)Total other income,net$290K (-57.97%↓ Y/Y)Total revenue$47,798K (16.47%↑ Y/Y)Other expense, net-$2,368K (-689.33%↓ Y/Y)Interest expense, net$432K (-25.90%↓ Y/Y)Loss from operations-$9,614K (-1.37%↓ Y/Y)Gross margin$21,913K (17.55%↑ Y/Y)Total cost of revenue$25,885K (15.56%↑ Y/Y)Total operating costsand expenses$31,527K (12.10%↑ Y/Y)Service$13,747K (-39.88%↓ Y/Y)Product$12,138K (-33.22%↓ Y/Y)Selling, general andadministrative$27,620K (14.17%↑ Y/Y)Engineering and development$3,907K (-0.69%↓ Y/Y)

Cryoport, Inc. (CYRX)

Cryoport, Inc. (CYRX)